These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8077494)

  • 1. Controversial aspects in the management of vulvovaginal candidiasis.
    Sobel JD
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S10-3. PubMed ID: 8077494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and significance of drug resistance in vulvovaginal candidiasis.
    Spinillo A; Nicola S; Colonna L; Marangoni E; Cavanna C; Michelone G
    Gynecol Obstet Invest; 1994; 38(2):130-3. PubMed ID: 7959341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
    Sobel JD; Sobel R
    Expert Opin Pharmacother; 2018 Jun; 19(9):971-977. PubMed ID: 29932786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
    Chew SY; Than LT
    Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined single-day treatment in acute vulvovaginal candidosis].
    Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
    Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vulvovaginal candidiasis].
    Svobodová L; Lysková P; Hamal P
    Klin Mikrobiol Infekc Lek; 2015 Sep; 21(3):74-81. PubMed ID: 26636630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems of vaginal candidiasis. III. The trends in current antimycotic therapy].
    Zlatkov V; Kantardzhiev T
    Akush Ginekol (Sofiia); 1990; 29(6):54-8. PubMed ID: 2100954
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for vulvovaginal candidiasis, 1993.
    Reef SE; Levine WC; McNeil MM; Fisher-Hoch S; Holmberg SD; Duerr A; Smith D; Sobel JD; Pinner RW
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S80-90. PubMed ID: 7795112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent vulvovaginal candidiasis.
    Sobel JD
    Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
    Fan S; Liu X; Wu C; Xu L; Li J
    Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    White DJ; Johnson EM; Warnock DW
    Genitourin Med; 1993 Apr; 69(2):112-4. PubMed ID: 8389723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with recurrent vulvovaginal candidiasis.
    Sobel JD
    Drugs; 2003; 63(11):1059-66. PubMed ID: 12749733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical inquiries. How should you treat Candida vaginitis in patients on antibiotics?
    Xu J; Schwartz K; Hitchcock K; Kittinger-Aisenberg L
    J Fam Pract; 2007 Aug; 56(8):671-2. PubMed ID: 17669295
    [No Abstract]   [Full Text] [Related]  

  • 16. Vulvovaginal candidiasis: topical vs. oral therapy.
    Tobin MJ
    Am Fam Physician; 1995 May; 51(7):1715-20, 1723-4. PubMed ID: 7754931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent vulvovaginal candidiasis.
    Ringdahl EN
    Mo Med; 2006; 103(2):165-8. PubMed ID: 16703718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
    Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
    N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis.
    Rohde-Werner H
    J Int Med Res; 1984; 12(5):298-302. PubMed ID: 6094282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.